A significant advance in cancer research is emerging with the use of mini-antibodies to re-engage dysfunctional p53. This essential cancer inhibitor protein is frequently lost in many forms of malignancies, causing https://bookmarksknot.com/story24005371/vhh-fragments-revive-tumor-suppressor-p53-a-promising-pathway-for-cancer-management